ArticleFrontiers in oncology2024

ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery.

August J John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.